organic cation transporter neurotransmitter optimization research
  NeuroResearch Clinics, Inc.
  AMA Category 1
  Continuing Medical Education
   
   
   
  Tahiti photo by Marty L. Hinz, MD
 

organic cation transporter neurotransmitter optimization RESEARCH

 

NeuroResearch Clinics neurotransmitter research

 
 
 
Contact us or find a caregiver using this approach.
 

organic cation transporter neurotransmitter optimization RESEARCH

Web site written by: Marty L. Hinz, MD
President Clinical Research
NeuroResearch Clinics, Inc.
Cape Coral, Florida USA Research Office
 

NeuroResearch Clinics: organic cation transporter neurotransmitter optimization

  This is an overview of how organic cation transporter neurotransmitter optimization found its place in the research of NeuroResearch Clinics. For an in depth discussion of organic cation transporter neurotransmitter optimization click on the "organic cation transporter neurotransmitter optimization" link in the black colored column to the left.

  The only viable option for clinical organic cation transporter neurotransmitter optimization application is urinary organic cation transporter neurotransmitter optimization. Due to limitations other organic cation transporter neurotransmitter optimization methods involving serum (blood), saliva, and central spinal fluid are not a viable option in the clinic.

  There are two types of labs in the world:

  • organic cation transporter neurotransmitter optimization preformed by laboratories directed by licensed hospital based medical doctors who are board certified in laboratory medicine.

  • organic cation transporter neurotransmitter optimization performed by Laboratories operated by chemists with no medical license.

  Early on NeuroResearch Clinics contracted for organic cation transporter neurotransmitter optimization laboratories from laboratories directed by chemists. This involved multiple laboratories. Reported laboratory results from the chemist laboratories caused a organic cation transporter neurotransmitter optimization confusion. The organic cation transporter neurotransmitter optimization lab data being reported was so flawed that it was discarded. The chemist labs expounded the belief that:

  • serotonin and dopamine found in the urine on organic cation transporter neurotransmitter optimization is simply filtered by the glomerulous of kidneys excreted into the urine

  • serotonin and dopamine cross the blood brain barrier therefore the serotonin and dopamine in the urine on organic cation transporter neurotransmitter optimization is serotonin and dopamine that was in the brain.

  • baseline organic cation transporter neurotransmitter optimization is needed prior to starting treatment.

  On review of the scientific literature these assertions are not true. The following is true:

  • serotonin and dopamine do not cross the blood brain barrier

  • serotonin and dopamine found in the urine on organic cation transporter neurotransmitter optimization are serotonin and dopamine synthesized by the kidney then excreted into the urine, virtually none of the serotonin and dopamine filtered by the kidneys make it to the urine, they are metabolized by the kidney.

  • baseline organic cation transporter neurotransmitter optimization prior to treatment is of no value and does not correlate with organic cation transporter neurotransmitter optimization once the patient is taking significant amounts of nutrients.

   It was also found that the organic cation transporter neurotransmitter optimization being reported by chemist labs were so flawed that results were discarded from research considerations. How was this realized? In 2003 Tom Uncini, MD hospital based dual board certified laboratory pathologist opened DBS Labs. It took Dr. Uncini 13 months to get precision and accuracy studies for organic cation transporter neurotransmitter optimization perfected. Once perfected statistical analysis revealed that the organic cation transporter neurotransmitter optimization of the chemist labs had no correlation with the results being reported by Tom Uncini, MD hospital based dual board certified pathologist. NeuroResearch Clinics determined that Dr. Uncini's lab was valid and went forward. By 2005 NeuroResearch Clinics defined the ground breaking concept of "the three phase response of urinary neurotransmitters during administration of nutrients".

  Intuitively one would think that giving 5-HTP increases urinary serotonin levels, this is not true. In 2008 the chairman of the research committee of the University of Minnesota Medical School wrote a paper based on the research work of NeuroResearch Clinics specifically noting in that analysis of urinary organic cation transporter neurotransmitter optimization revealed no correlation between 5-HTP and urinary serotonin. Serotonin and dopamine exists is two states "the endogenous state" found when people are taking no serotonin and dopamine nutrients and "the competitive inhibition state" found when people are taking serotonin and dopamine nutrients. These two states have no correlation. There is no correlation with baseline organic cation transporter neurotransmitter optimization and organic cation transporter neurotransmitter optimization performed when taking significant amounts of serotonin and dopamine nutrients.

organic cation transporter neurotransmitter optimization RESEARCH

- Home Page

- Doctor testimonials

- What are neurotransmitters?

- Neurotransmitter Research history

- organic cation transporter neurotransmitter optimization research

- Weight loss expertise

- Links

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
     
     
     
organic cation transporter neurotransmitter optimization RESEARCH   organic cation transporter neurotransmitter optimization RESEARCH
     
     
     
     

 

   
 
If you need a medical speaker for AMA Category I CME call NeuroResearch Clinics, Inc.
NeuroResearch Clinics, Inc. only deals with and provides information to licensed health care professionals.
 
keyz keyb